BioAge Labs, Inc.
BIOA
$4.38
$0.153.55%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -71.11M | -70.94M | -62.16M | -65.76M | -63.85M |
| Total Depreciation and Amortization | 167.00K | 161.00K | 171.00K | 162.00K | 162.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.24M | 13.77M | 17.08M | 20.21M | 19.62M |
| Change in Net Operating Assets | 11.18M | 2.12M | -2.82M | 2.36M | 6.71M |
| Cash from Operations | -51.52M | -54.89M | -47.72M | -43.03M | -37.36M |
| Capital Expenditure | -366.00K | -340.00K | -134.00K | -155.00K | -166.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | 0.00 | -100.00K |
| Cash from Investing | -366.00K | -340.00K | -134.00K | -155.00K | -266.00K |
| Total Debt Issued | -- | 0.00 | 0.00 | 12.50M | 36.00M |
| Total Debt Repaid | -6.00M | -5.50M | -4.00M | -2.50M | -1.00M |
| Issuance of Common Stock | 222.25M | 194.61M | 429.00K | 7.00K | 4.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 170.04M | 170.04M | 169.50M | 169.50M | -- |
| Repurchase of Preferred Stock | -40.00K | -40.00K | -40.00K | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.05M | -3.82M | -1.32M | -59.00K | -63.00K |
| Cash from Financing | 381.20M | 355.29M | 164.56M | 179.45M | 34.94M |
| Foreign Exchange rate Adjustments | 81.00K | -121.00K | -28.00K | 31.00K | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 329.39M | 299.94M | 116.68M | 136.29M | -2.69M |